All posts
Press releases
2
min

VISFO launches new website to reflect a sharper, smarter vision for pharma intelligence

Published on
May 7, 2025
Contributors
Charlie Brook
Commercial Director

VISFO, a leader in precision intelligence and strategic consulting for the pharmaceutical industry, has launched a redesigned website that reflects its sharper value proposition, simplified service offering, and evolving vision.

The new site is purpose-built to help pharma teams understand VISFO’s unique approach. How it helps companies make smarter decisions earlier in the development lifecycle by removing traditional barriers around data access and cost. With a streamlined user experience and clearer messaging, the site showcases VISFO’s two flagship offerings:

  • HelixAI, the company’s proprietary knowledge management system, and
  • Expert-led consulting, designed to support strategic decisions across Market Access, Medical Affairs, and Clinical Development.

“Over the past six months, we’ve gained real clarity on how our technology and consulting work together to solve our clients’ biggest challenges,” said Dr Max Noble - CEO of VISFO. “The new site reflects that evolution. Showing the impact we can deliver, without making people dig for it.”

Key upgrades to the site include:

  • Cleaner navigation and simplified structure to highlight VISFO’s core value
  • A new Resources section featuring thought leadership and use cases
  • Clearer explanation of how VISFO integrates tech, data, and deep domain expertise
  • Dedicated pages for both HelixAI and consulting, with real-world examples

The launch marks the next step in VISFO’s mission to help pharma companies navigate increasingly complex scientific, clinical, and market landscapes with clarity, speed, and confidence.

Visit the new site at https://www.visfo.health

About VISFO

VISFO is a UK-based company combining data science, advanced technology, and deep domain expertise to help pharma teams make smarter decisions, earlier. Its precision intelligence platform, HelixAI, and expert-led consulting services support key strategic functions including Market Access, Medical Affairs, and Clinical Development.